Heather Quintana Suchan, a mother and music industry professional living with stage 4 lung cancer, shared how her diagnosis ...

A prolonged disease trajectory complicates “survivor” identity, particularly when remission follows transplant yet later ...

Heather Quintana Suchan, a mother living with stage 4 lung cancer, is using her platform to encourage other patients to pursue biomarker testing and genomic profiling early in the diagnostic process, ...

Liver cancer survivor and patient advocate Charles Walker joined CURE’s Gina Mauro, vice president of content at MJH Life Sciences, to share his experience with transplant, living donation and ...

With this decision, Optune Pax becomes the first new FDA-approved treatment for locally advanced pancreatic cancer in decades. For patients and families navigating this diagnosis, the addition of a ...

Dr. Sue Hwang, a radiation oncologist and breast cancer survivor, sheds light on the reality of cancer survivorship. Dr. Sue Hwang is incredibly familiar with the misconceptions that come during a ...

Heather Quintana Suchan says early biomarker testing at diagnosis helped match her to Rybrevant and urges patients to personalize care and stay active during treatment.

A three-time cervical cancer survivor urges patients with cancer to be thorough, seek multiple opinions and trust their gut to find providers who listen, validate concerns and truly support them.

Human cohort studies and meta-analyses have not shown increased incidence of common differentiated thyroid cancers with GLP-1 receptor agonist exposure. Rodent C-cell tumor signals underpin the boxed ...

Colleen Mabasa, a patient with multiple myeloma, sat down with CURE for an interview to discuss how she pursued chimeric antigen receptor (CAR)-T cell therapy, navigated insurance and logistical ...

The FDA has accepted a sNDA for Ameluz topical gel, used in combination with the RhodoLED red-light lamp series, for superficial basal cell carcinoma treatment.

The FDA has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneous, chemo-free ...